Ghent University Academic Bibliography

Your filters: cql: author="Rowe, Paul" or (type any "bookEditor issueEditor" and editor="Rowe, Paul")

Add to list
- Journal Article
- A1
- open access
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Claus Bachert (UGent) , Philippe Gevaert (UGent) , Brian Lipworth, Syed Shahzad Mustafa, Andrew P. Lane, Joaquim Mullol, Paul Rowe, Yamo Deniz, Siddhesh Kamat, Asif H. Khan, et al.

(2024) ALLERGY. 79(10). p.2858-2861
Add to list
- Journal Article
- A1
Response to the correspondence : 'Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma'

Eric D Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Paul Rowe, Heather Burnett, Jerome Msihid, David Weinreich and Ian Pavord

(2022) RESPIRATORY MEDICINE. 191.
Add to list
- Journal Article
- A1
- open access
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma

Eric D Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather Burnett, Jerome Msihid and David Weinreich

(2022) RESPIRATORY MEDICINE. 191.
Add to list
- Conference Paper
- C3
Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies

Seong Cho, Bruce Tan, Noam Cohen, Jody Tversky, Elina Toskala, Scott Nash, Haixing Zhang, Shahid Siddiqui, Asif H. Khan, Juby Jacob-Nara, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB143-AB143
Add to list
- Conference Paper
- C3
Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Claire Hopkins, Stella Lee, Wytske Fokkens, Eugene Chang, Jérôme Msihid, Asif H. Khan, Urvi Mujumdar, Siddhesh Kamat, Scott Nash, Shahid Siddiqui, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB142-AB142
Add to list
- Journal Article
- A1
- open access
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, Nobuo Ohta, Mikiya Asako, Claus Bachert (UGent) , Tomoyuki Inoue, Yoshinori Takahashi, Hiroyuki Fujita, Yamo Deniz, et al.

(2022) ALLERGY. 77(1). p.186-196
Add to list
- Conference Paper
- C3
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Andrew Lane, Joaquim Mullol, Claire Hopkins, Wytske Fokkens, Stella Lee, Asif H. Khan, Jérôme Msihid, Scott Nash, Shahid Siddiqui, Urvi Mujumdar, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144
Add to list
- Conference Paper
- C3
SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials

Joaquim Mullol, Giorgio Walter Canonica, Martin Wagenmann, Andre Coste, Peter Hellings, Scott Nash, Siddhesh Kamat, Urvi Mujumdar, Jérôme Msihid, Asif H. Khan, et al.

(2021) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 58(supplement 65).
Add to list
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Claire Hopkins, Martin Wagenmann, Claus Bachert (UGent) , Martin Desrosiers, Joseph K. Han, Peter W. Hellings, Stella E. Lee, Jerome Msihid, Amr Radwan, Paul Rowe, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(7). p.1087-1101
Add to list
- Conference Paper
- C3
Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Ian Pavord, William Busse, Elliot Israel, Stanley Szefler, Zhen Chen, Nadia Daizadeh, David Lederer, Leda Mannent, Nikhil Amin, Elizabeth Laws, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(supplement 2). p.AB4-AB4

Academic Bibliography

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Response to the correspondence : 'Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma'

Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma

Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies

Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Contents

Support

Contact